Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Dabigatranetexilate

Research Leaders

5 sponsors active, led by Assiut University

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Unknown3
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Dabigatranetexilate1
  • Repeated Cardiac Computed Tomography1
  • Transesophageal Echo1
  • Cardiac Computed Tomography1
  • Cardiac Magnetic Resonance1

Active Sponsors

  • Assiut University1
  • Rambam Health Care Campus1
  • University of Ulm1
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
  • Boehringer Ingelheim1

Top Investigators

Related Conditions

  • Atrial Fibrillation2
  • Thrombus Embolism1
  • Ischemic Stroke1
  • Cardioembolic Stroke1
  • Left Atrial Appendage Thrombosis1

Activity Timeline